Next-generation sequencing

Providing clarity and actionable results

The diagnosis of bleeding and thrombosis disorders relies heavily on specialized coagulation assays, but genotype assays are increasing in utility and availability.

Created to meet the growing needs of our own clinical practice, we offer a comprehensive next-generation sequencing menu for patients who have bleeding and thrombosis disorders.

Next-generation sequencing Test menu

More information

NGS testing can provide useful information that assists physicians including:

  • Confirming the diagnosis of bleeding and thrombosis disorders.
  • Providing clarity and actionable results in situations where other testing methodologies provide inconclusive results for patients.
  • Identifying mutations that could explain patients’ unusual hemostatic phenotype and laboratory results.
  • Assays with single/small gene panels, focused panels, and comprehensive panels for bleeding/coagulation disorders, coagulation/angioedema, fibrinogen disorders, and thrombosis disorders.

Bleeding disorders single/small gene panels

Key testing


Bleeding disorders focused panels

Key testing


Bleeding disorders comprehensive panel

Key testing


Thrombosis disorders single/small gene panels

Key testing


Thrombosis disorders comprehensive panel 

Key testing


Platelet disorders single/small gene panels

Key testing


Platelet disorders focused panels

Key testing


Platelet disorders comprehensive panel

Key testing

INTERESTED IN LEARNING MORE?

Fill out the form below and one of our specialists will be in touch.